InsidersTradesSigma
Alaunos Therapeutics, Inc.: directors' dealings · United States · SEC (Form 4)
SEC:alaunos-therapeutics-inc-e3774cUS·SEC (Form 4)Mcap 6M€Healthcare
Explore the full directors' dealings record of Alaunos Therapeutics, Inc., a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Alaunos Therapeutics, Inc. has logged 9 insider filings. Market capitalisation: €6.2m. The latest transaction was disclosed on 24 June 2022 (Attribution). Among the most active insiders: Huang James. Every trade is free.
9
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2.58 €
Analyst consensus
Income statement
Revenue5 k€
Net income−4.2 M€-83520.0% margin
Valuation
P/Book2.0x
Beta-1.13
Balance sheet & cash
Market cap6.2 M€
Free Cash Flow−3.0 M€
Profitability & ownership
ROE-198.1%
ROA-92.3%
% insiders14.1%
% institutions6.6%
Last declaration on 24 June 2022
Declarations0 total
No declarations found
0 of 0 declarations